New 2024 Clinical Trial For Memory Loss Available
We’re excited to announce that our practice is one of 6 sites in the country selected for the Evanthea Dementia Reversal Trial!
Evanthea is a group of brain and precision medicine experts evaluating the effects of a novel precision medicine and lifestyle intervention treatment approach for memory loss reversal in early dementia and mild cognitive impairment.
They are seeking participants for a 9-month clinical trial testing a new approach to treating memory loss in early dementia and mild cognitive impairment. The treatment combines precision medicine and lifestyle interventions.
If you are between 45-76 years old and live within an hour of one of the six trial sites below, you may be eligible to participate.
This is a randomized, controlled clinical trial using precision medicine, which is a novel approach involving comprehensive testing along with functional and lifestyle interventions for the treatment of mild cognitive impairment or early-stage dementia. This is a completely different way of looking at and treating memory loss that impacts so many.
Eligible participants will be randomized into a 9-month precision medicine treatment approach or a 9-month standard-of-care treatment approach.
Locations of the precision medicine clinical practices participating in the trial are:
- Folsom, CA
- San Rafael, CA
- Walnut Creek, CA
- Hollywood, Florida – Rezilir Health, 1930 Harrison St., Suite 404, Hollywood, Florida 33020
- Rocky River, OH
- Nashville, TN
If you or anyone you know is interested in being part of this trial, please sign up at the official website: DementiaReversalTrial.com
A potential candidate may have any of the below early dementia and mild cognitive impairment symptoms:
- Recently more forgetful
- Difficulty finding words
- Needs a list for everything
- Lost while walking or driving
- Difficulty with arithmetic
- Familiar tasks are difficult
This is a revolutionary trial that our practice is proud to be a part of. We believe it has the potential to positively impact the future of medicine and how we treat early dementia and mild cognitive impairment.
Medical clinical trials are the cornerstone of medical progress. Without them, there would be no way to safely test new treatments and see if they’re truly effective. In the field of cognitive health, this is especially important for diseases like Alzheimer’s.
Clinical trials allow researchers to evaluate potential treatments for memory loss and dementia, paving the way for new approaches that could slow or even reverse these conditions. By participating in these trials, individuals contribute directly to finding a cure for Alzheimer’s and improving the lives of millions.
We encourage you to share the news of this exciting clinical trial.
Respectfully,
Dr. Craig Tanio
Rezilir Health
